180 related articles for article (PubMed ID: 16630118)
1. Expression patterns of polo-like kinase 1 in human gastric cancer.
Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
[TBL] [Abstract][Full Text] [Related]
2. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
Jang YJ; Kim YS; Kim WH
Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
[TBL] [Abstract][Full Text] [Related]
5. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
[TBL] [Abstract][Full Text] [Related]
7. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.
Ito R; Oue N; Zhu X; Yoshida K; Nakayama H; Yokozaki H; Yasui W
Virchows Arch; 2003 Feb; 442(2):118-23. PubMed ID: 12596061
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer.
Weichert W; Schmidt M; Jacob J; Gekeler V; Langrehr J; Neuhaus P; Bahra M; Denkert C; Dietel M; Kristiansen G
Pancreatology; 2005; 5(2-3):259-65. PubMed ID: 15855824
[TBL] [Abstract][Full Text] [Related]
10. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
Cheng MW; Wang BC; Weng ZQ; Zhu XW
Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 1 expression is a prognostic factor in human colon cancer.
Weichert W; Kristiansen G; Schmidt M; Gekeler V; Noske A; Niesporek S; Dietel M; Denkert C
World J Gastroenterol; 2005 Sep; 11(36):5644-50. PubMed ID: 16237758
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
14. [Expression of checkpoint kinase 1 and polo-like kinase 1 and its clinicopathological significance in benign and malignant lesions of the stomach].
Yao H; Yang Z; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1080-4. PubMed ID: 21051833
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
Liu L; Zhang M; Zou P
Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.
Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Sharrocks AD; Ang YS
BMC Res Notes; 2015 Nov; 8():676. PubMed ID: 26576650
[TBL] [Abstract][Full Text] [Related]
18. High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence.
Takagawa R; Akimoto K; Ichikawa Y; Akiyama H; Kojima Y; Ishiguro H; Inayama Y; Aoki I; Kunisaki C; Endo I; Nagashima Y; Ohno S
Ann Surg Oncol; 2010 Jan; 17(1):81-8. PubMed ID: 19774416
[TBL] [Abstract][Full Text] [Related]
19. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
[TBL] [Abstract][Full Text] [Related]
20. [Mitosis arrest caused by inhibition of PLK1 expression in gastric cancer MKN45 cells].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):164-8. PubMed ID: 16875597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
